Page last updated: 2024-10-22

amifostine anhydrous and Hepatic Veno Occlusive Disease

amifostine anhydrous has been researched along with Hepatic Veno Occlusive Disease in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

ExcerptRelevanceReference
"The purpose of the study was to draw upan experimental model of hepatic veno-occlusive disease (VOD) induced by dactinomycin (ACT) and to investigate the possible hepatoprotective effects of Ethyol (amifostine)."3.72Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope. ( Arciszewska, E; Borowska, H; Czauderna, P; Sawicki, B, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borowska, H1
Arciszewska, E1
Czauderna, P1
Sawicki, B1

Other Studies

1 other study available for amifostine anhydrous and Hepatic Veno Occlusive Disease

ArticleYear
Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope.
    Folia morphologica, 2004, Volume: 63, Issue:1

    Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Dactinomycin; Drug Antagonism; Glycogen; Hepatic V

2004